EUVIMEDEUVIMED entdecken
Fallbericht

Coproporphyrinogen Oxidase Deficiency Causes Primary Adrenal Insufficiency and 46,XY DSD

Misa Honda iD, Satoshi Narumi iD, Kosei Hasegawa iD, Yoshimitsu Goto, Yusuke Kawashima, Osamu Ohara iD, Ryuji Fukuzawa, Tomohiro Ishii iD, Tomonobu Hasegawa iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf329 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Misa Honda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan. Hauptthemen laut MEDLINE: Adrenal Insufficiency, Coproporphyrinogen Oxidase, Disorder of Sex Development, 46,XY. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: The Japanese Society for Pediatric Endocrinology Future Development, The Ministry of Health, Labour and Welfare of Japan, Japan Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Primary adrenal insufficiency (PAI) is a rare, life-threatening condition, and at times is associated with differences of sexual differentiation (DSD). Cytochrome P450 enzymes, which are essential for steroidogenesis in adrenals and gonads, have heme in their active center. CPOX encodes an enzyme coproporphyrinogen oxidase (CPOX) that is involved in the synthesis of heme.

Objective

This study aims to report the identification of biallelic inactivating CPOX variants in 3 unrelated patients with PAI and their clinical characteristics.

Methods

We report 3 patients with childhood-onset PAI, including 2 with 46,XY DSD. All 3 had adrenal hypoplasia. Additionally, they commonly had severe neonatal jaundice; 2 developed skin blisters in the areas exposed to phototherapy and 2 showed severe neonatal anemia requiring transfusions. Exome sequencing was performed to explore the genetic basis of the patients. The pathogenicity of the identified variants was confirmed with targeted mRNA and proteomic analyses of the patient-derived peripheral blood cells.

Results

We identified biallelic rare CPOX variants in each patient, including c.2T > G, p.Arg426*, c.1277G > A, and p.Tyr429Cysfs33*. The 3 patients commonly had the start codon-altering c.2T > G variant. Analysis of the mRNA and proteome of peripheral blood cells from 1 patient (c.2T > G and p.Arg426*) showed that CPOX mRNA expression was comparable to controls; however, CPOX protein expression was significantly decreased to 1%.

Conclusion

We provided genetic evidence linking CPOX deficiency and PAI with 46,XY DSD, suggesting that the heme synthesis pathway plays an important role in human steroidogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal InsufficiencyCoproporphyrinogen OxidaseDisorder of Sex Development, 46,XYFemaleHumansMaleMutationAdolescentYoung AdultAdult

Stichwörter der Autor:innen

adrenal insufficiencycoproporphyrinogen oxidasedisorder of sex developmentgeneticsmutation

Substanzen

Coproporphyrinogen Oxidase

Autor:innen und Institutionen

  • Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Department of Pediatrics, Okayama University Hospital, Kitaku, Okayama 700-8558, Japan.
  • Department of Pediatric Nephrology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Showa-ku Nagoya City, Aichi 466-8650, Japan.
  • Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu City, Chiba 292-0818, Japan.
  • Department of Pathology, School of Medicine, International University of Health and Welfare, Narita City, Chiba 286-8686, Japan.

ORCID-Profile: Misa Honda, Satoshi Narumi, Kosei Hasegawa, Osamu Ohara, Tomohiro Ishii, Tomonobu Hasegawa

Förderung

  • The Japanese Society for Pediatric Endocrinology Future Development
  • The Ministry of Health, Labour and Welfare of Japan
  • Japan Agency
  • Medical Research and Development

Zitieren

APA

Honda, M., Narumi, S., Hasegawa, K., Goto, Y., Kawashima, Y., Ohara, O., Fukuzawa, R., Ishii, T., & Hasegawa, T. (2025). Coproporphyrinogen Oxidase Deficiency Causes Primary Adrenal Insufficiency and 46,XY DSD. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf329

Vancouver

Honda M, Narumi S, Hasegawa K, Goto Y, Kawashima Y, Ohara O, et al. Coproporphyrinogen Oxidase Deficiency Causes Primary Adrenal Insufficiency and 46,XY DSD. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf329

BibTeX
@article{Honda2025,
  author = {Honda, Misa and Narumi, Satoshi and Hasegawa, Kosei and Goto, Yoshimitsu and Kawashima, Yusuke and Ohara, Osamu and Fukuzawa, Ryuji and Ishii, Tomohiro and Hasegawa, Tomonobu},
  title = {Coproporphyrinogen Oxidase Deficiency Causes Primary Adrenal Insufficiency and 46,XY DSD},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf329}
}
Kostenlos starten →